4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-23-012224
Director acquired 3,739 shares (code L)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krogulski Kenneth Director | 2023-08-16 | Other acquisition 10b5-1 | +325 | $1.67 | $543 | 210,280 | D |
| Krogulski Kenneth Director | 2023-08-17 | Other acquisition 10b5-1 | +325 | $1.73 | $562 | 210,605 | D |
| Krogulski Kenneth Director | 2023-08-18 | Other acquisition 10b5-1 | +325 | $1.73 | $562 | 210,930 | D |
| Krogulski Kenneth Director | 2023-08-21 | Other acquisition 10b5-1 | +325 | $1.71 | $556 | 211,255 | D |
| Krogulski Kenneth Director | 2023-08-22 | Other acquisition 10b5-1 | +325 | $1.75 | $569 | 211,580 | D |
| Krogulski Kenneth Director | 2023-08-23 | Other acquisition 10b5-1 | +325 | $1.73 | $562 | 211,905 | D |
| Krogulski Kenneth Director | 2023-08-24 | Other acquisition 10b5-1 | +134 | $1.69 | $226 | 212,039 | D |
| Krogulski Kenneth Director | 2023-08-25 | Other acquisition 10b5-1 | +325 | $1.73 | $562 | 212,364 | D |
| Krogulski Kenneth Director | 2023-08-28 | Other acquisition 10b5-1 | +325 | $1.74 | $566 | 212,689 | D |
| Krogulski Kenneth Director | 2023-08-29 | Other acquisition 10b5-1 | +355 | $1.70 | $604 | 213,044 | D |
| Krogulski Kenneth Director | 2023-08-30 | Other acquisition 10b5-1 | +325 | $1.71 | $556 | 213,369 | D |
| Krogulski Kenneth Director | 2023-08-31 | Other acquisition 10b5-1 | +325 | $1.70 | $553 | 213,694 | D |
Loading xslF345X05/marketforms-62561.xml…